# Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3)

> **NCT01515007** · PHASE3 · COMPLETED · sponsor: **Aradigm Corporation** · enrollment: 278 (actual)

## Conditions studied

- Non Cystic Fibrosis Bronchiectasis

## Interventions

- **DRUG:** Ciprofloxacin dispersion for inhalation
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01515007
- **Lead sponsor:** Aradigm Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-31
- **Primary completion:** 2016-08-17
- **Final completion:** 2016-10
- **Target enrollment:** 278 (ACTUAL)
- **Last updated:** 2021-03-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01515007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01515007, "Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01515007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*